In about 5–10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients. Research from Radboud ...
In about 5–10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.
New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.
For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...
Guardant Health's Shield blood test for colorectal cancer screening is now covered by TRICARE, providing active duty service ...
A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...
North Lamar High School HOSA students recently presented a $2,858 donation to the Paris Lamar County Health District (PLCHD) ...
Guardant Health, Inc., a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening is now covered for active-duty service members and their families ...
Experts point to a combination of environmental factors and lifestyle factors, such as diets high in red meat and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback